Perrigo: Beginning With the 4Q and full-Yr 2026 Reporting, the Infant Formula Business Will Be Reported as Discontinued Ops >PRGO

What happened

Perrigo says that beginning with its fourth-quarter and full-year 2026 reporting, it will present its infant formula business as discontinued operations, a reporting category for business activities treated separately from ongoing operations.

Confirmed

Global impact / market context

Separating infant formula from ongoing operations will change how investors read Perrigo’s reported results, making comparisons with earlier periods less direct. It does not, by itself, establish that the business has been sold or that company revenue or cash flow will change.

Analyst inference

The announcement concerns financial reporting rather than a stated operational change. Investors assessing Perrigo’s performance may need to distinguish the separately reported infant formula business from ongoing operations; the supplied text gives no details about a sale, financial impact, or reason for the classification.

Analyst inference

What to watch

1. Check Perrigo’s fourth-quarter and full-year 2026 reports for how infant formula results are presented separately and whether comparable earlier figures are provided. Analyst inference
2. Look for company details explaining why the business is classified as discontinued operations and whether any sale or other transaction is involved. Analyst inference
3. Assess whether separate reporting changes investors’ view of ongoing revenue, costs, or cash generation; the supplied announcement provides no figures for those effects. Analyst inference

Evidence

• Original source link unavailable